Trigger-Point
发表于 2025-3-23 13:39:41
Chih-Chang Chang,Lung-Ming Fu,Ruey-Jen Yangreatment of melanoma and some skin cancers, possibility of using .F-FDG PET-CT to monitor response and predict long-term outcome is under investigation. However, we should be aware of the fact that .F-FDG uptake is not specific for malignant neoplasms since inflammation, infection, or a benign tumor can show focal .F-FDG uptake.
话
发表于 2025-3-23 14:24:51
http://reply.papertrans.cn/16/1595/159418/159418_12.png
整理
发表于 2025-3-23 19:40:45
http://reply.papertrans.cn/16/1595/159418/159418_13.png
defenses
发表于 2025-3-23 22:55:29
F-18 FDG PET Tests in Malignant Lymphoma,esponse assessment. Although its usefulness remains under investigation, interim PET is expected to become a useful biomarker for the prediction of treatment outcome and the stratification of treatment.
古代
发表于 2025-3-24 04:02:58
Book 2021, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes i
过于平凡
发表于 2025-3-24 08:11:36
http://reply.papertrans.cn/16/1595/159418/159418_16.png
integrated
发表于 2025-3-24 11:11:00
http://reply.papertrans.cn/16/1595/159418/159418_17.png
canonical
发表于 2025-3-24 18:12:26
http://reply.papertrans.cn/16/1595/159418/159418_18.png
凝视
发表于 2025-3-24 22:13:18
http://reply.papertrans.cn/16/1595/159418/159418_19.png
NICE
发表于 2025-3-25 02:40:38
Actinides, Interactions with Proteinscused only on therapeutic monitoring. This study reviewed and discussed the role of therapeutic monitoring of molecular target agents, angiogenetic inhibitors, and immune checkpoint inhibitors (ICIs) in patients with lung cancer. ICIs including anti-programmed death-1 (PD-1)/programmed death-ligand